Ligand validation:6EHD

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 6EHD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.42	1.08	-	2	3	0	100%	1
6EHD_C8E_A_405	51%	65%	0.096	0.916	0.41	0.92	-	-	0	0	62%	0.619
6EHD_C8E_A_407	49%	73%	0.114	0.901	0.49	0.54	-	-	0	0	76%	0.7619
6EHD_C8E_A_404	46%	48%	0.132	0.865	0.64	1.33	-	5	2	0	100%	1
6EHD_C8E_A_401	28%	65%	0.14	0.86	0.56	0.78	-	-	0	0	62%	0.619
6EHD_C8E_A_410	23%	67%	0.141	0.837	0.37	0.89	-	-	3	0	57%	0.5714
6EHD_C8E_A_402	20%	70%	0.112	0.841	0.6	0.56	-	-	0	0	29%	0.2857
6EHD_C8E_A_403	16%	87%	0.175	0.844	0.48	0.22	-	-	0	0	43%	0.4286
6EHD_C8E_A_406	8%	15%	0.192	0.751	1.03	2.7	1	3	6	0	52%	0.5238
6EHD_C8E_A_408	3%	63%	0.172	0.572	0.67	0.74	-	-	0	0	62%	0.619
6EHE_C8E_A_401	29%	87%	0.143	0.931	0.45	0.24	-	-	0	0	29%	0.2857
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1
3RGM_C8E_A_800	66%	65%	0.12	0.924	0.48	0.85	-	1	1	0	100%	1
5DL7_C8E_A_506	61%	46%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1
5MDO_C8E_F_404	60%	76%	0.131	0.949	0.38	0.56	-	-	0	0	81%	0.8095

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.